Rong Deng
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 18
- Ubiquitin and proteasome pathways 15
-
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 15
- Co-authors
- Xiao‐Feng Zhu (37 shared papers)Gong-Kan Feng (28 shared papers)Dandan Li (12 shared papers)Jun Tang (21 shared papers)Jianxiu Yu (22 shared papers)Xiao‐Feng Zhu (31 shared papers)Gong‐Kan Feng (26 shared papers)Xian Zhao (18 shared papers)
- Journals
- Oncotarget (7 papers)Oncogene (6 papers)Autophagy (5 papers)Molecular Cancer (5 papers)Nature Communications (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Rong Deng
185 papers receiving 6.4k citations
Rong Deng's Hit Papers
Peers
Comparison fields: 5 of 184
- Cancer Research 2.1k
- Molecular Biology 4.0k
- Geriatrics and Gerontology 135
- Oncology 935
- Epidemiology 1.1k
Countries citing papers authored by Rong Deng
This map shows the geographic impact of Rong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Deng more than expected).
Fields of papers citing papers by Rong Deng
This network shows the impact of papers produced by Rong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Deng. The network helps show where Rong Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Rong Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 197 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis Hit paper breakdown → | 2022 | 394 |
| 2 | LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer Hit paper breakdown → | 2019 | 374 |
| 3 | 2014 | 259 | |
| 4 | 2018 | 244 | |
| 5 | 2008 | 231 | |
| 6 | 2017 | 201 | |
| 7 | 2015 | 181 | |
| 8 | 2008 | 161 | |
| 9 | 2020 | 147 | |
| 10 | 2020 | 136 | |
| 11 | 2021 | 133 | |
| 12 | 2015 | 132 | |
| 13 | 2021 | 127 | |
| 14 | 2013 | 94 | |
| 15 | 2005 | 94 | |
| 16 | 2012 | 90 | |
| 17 | 2019 | 87 | |
| 18 | 2019 | 80 | |
| 19 | 2012 | 80 | |
| 20 | 2017 | 80 |
About Rong Deng
Rong Deng is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Immunology, having authored 197 papers that have together received 6.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), MicroRNA in disease regulation (16 papers), Autophagy in Disease and Therapy (15 papers), Cancer-related molecular mechanisms research (15 papers), Ubiquitin and proteasome pathways (15 papers), Innovations in Concrete and Construction Materials (9 papers), Marine Sponges and Natural Products (8 papers) and Microbial Natural Products and Biosynthesis (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (4.0k citations), Geriatrics and Gerontology (135 citations), Oncology (935 citations) and Epidemiology (1.1k citations). Rong Deng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiao‐Feng Zhu, Gong-Kan Feng, Dandan Li, Jun Tang, Jianxiu Yu, Xiao‐Feng Zhu, Gong‐Kan Feng, Xian Zhao, Zhi‐Ling Li and Yuhong Chen. Their work appears in journals such as Oncotarget, Oncogene, Autophagy, Molecular Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.